1. Department of Medicine, Queen’s University, Kingston, ON, Canada;
2. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;
3. Pharmacology Consulting, Princeton Junction, NJ;
4. Rutgers–Robert Wood Johnson Medical School, New Brunswick, NJ;
5. Department of Pediatrics, Washington University in St. Louis, St. Louis, MO;
6. Division of Thrombosis and Hemostasis, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands;
7. Marseille, France;
8. Diagnostic Laboratories, Versiti Blood Research Institute, Milwaukee, WI;
9. Auburn, ME;
10. Bloodworks Northwest, Seattle, WA;
11. Division of Hematology, University of Washington, Seattle, WA;
12. National Women’s Health, Auckland City Hospital, Auckland, New Zealand;
13. Northern Cancer Service, Launceston General Hospital, Launceston, TAS, Australia;
14. Versiti Blood Research Institute, Milwaukee, WI;
15. Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland;
16. Coraopolis, PA;
17. Aflac Cancer and Blood Disorders, Children’s Healthcare of Atlanta, Emory University, Atlanta, GA;
18. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and
19. Outcomes and Implementation Research Unit, Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS